The latest addition to the Haynes Cardiovascular Institute capabilities is our Structural Heart Program, which will provide our community with access to a multidisciplinary team performing minimally invasive treatments to replace damaged heart valves, as well as treat other common heart defects like patent foramen ovale (PFO) and atrial septal defect (ASD).
What is Structural Heart Disease?
Structural heart disease refers to congenital or acquired defects in the heart's valves, wall, or chambers. While open heart surgery has been the most common method for fixing most of these problems, we now have minimally invasive, or 'percutaneous', options that are just as effective.
What Conditions Will the Program Treat?
The program will treat aortic stenosis as well as mitral valve issues, patent foramen ovales (PFOs), atrial septal defects (ASD) and left atrial appendage closure (for patients with Atrial Fibrillation who cannot take blood thinners). These minimally invasive therapies provide patients with an alternative to traditional open heart surgery. These are two of the proven procedures now available through our Structural Heart Program:
Transcatheter Aortic Valve Replacement (TAVR): A lifesaver for aortic stenosis patients. This minimally invasive procedure replaces a damaged aortic valve without removing it or surgically opening the chest.
Atrial Appendage Closure (Watchman Implant): This implantable device reduces the risk of stroke in people with atrial fibrillation who need an alternative to blood thinning medication. This minimally invasive procedure prevents the formation of dangerous blood clots in the heart that can lead to stroke.